Literature DB >> 7913379

Regulation of aromatic L-amino acid decarboxylase in rat striatal synaptosomes: effects of dopamine receptor agonists and antagonists.

M Y Zhu1, A V Juorio, I A Paterson, A A Boulton.   

Abstract

1. In this study we investigated the effects of dopamine receptor agonists and antagonists on rat striatal synaptosomal aromatic L-amino acid decarboxylase (AADC) activity. 2. The results show that 10(-5)-10(-7) M cis-flupenthixol increased the striatal synaptosomal AADC activity (by 25% to 57%) in a time-dependent manner. SCH 23390 and remoxipride alone had little or no effect on striatal synaptosomal AADC activity, but in combination they increased AADC activity by 20%, suggesting that the increases in striatal synaptosomal AADC activity occurred only after blockade of both dopamine D1 and D2 receptors. 3. Treatment with (+)-amphetamine and (+/-)-2-(N-phenylethyl-N-propyl)amino-5- hydroxytetralin hydrochloride ((+/-)-PPHT) produced a reduction of striatal synaptosomal AADC activity in a concentration- and time-dependent manner. SKF 38393 and (-)-quinpirole, however, exhibited no effect on striatal synaptosomal AADC activity, suggesting that only the mixed dopamine receptor agonists can reduce the AADC activity. Incubation with apomorphine at a concentration of 10(-4) M inhibited the AADC activity by 74% and this inhibition cannot be antagonized by SCH 23390, remoxipride or cis-flupenthixol, suggesting that apomorphine-induced inhibition of striatal synaptosomal AADC activity was not mediated by dopamine receptors. 4. cis-Flupenthixol can reverse the reduction of AADC activity induced by (+)-amphetamine and (+/-)-PPHT. The inhibition of AADC activity elicited by (+/-)-PPHT also can be reversed by SCH 23390 and remoxipride. 5. The inhibition of striatal synaptosomal AADC activity induced by (+/-)-PPHT is calcium-dependent and protein kinase C may play a role in the regulation of striatal AADC activity. 6. These studies show that striatal synaptosomal AADC activity is regulated by dopamine receptors and indicate that in vitro dopamine DI and D2 receptors have a synergistic effect in this regulation.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7913379      PMCID: PMC1910301          DOI: 10.1111/j.1476-5381.1994.tb13023.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  48 in total

1.  Aromatic L-amino acid decarboxylase.

Authors:  W LOVENBERG; H WEISSBACH; S UDENFRIEND
Journal:  J Biol Chem       Date:  1962-01       Impact factor: 5.157

2.  Direct phosphorylation of brain tyrosine hydroxylase by cyclic AMP-dependent protein kinase: mechanism of enzyme activation.

Authors:  T H Joh; D H Park; D J Reis
Journal:  Proc Natl Acad Sci U S A       Date:  1978-10       Impact factor: 11.205

3.  Stability of synaptosomal GABA levels and their use in determining the in vivo effects of drugs: convulsant agents.

Authors:  J D Wood; M P Russell; E Kurylo; J D Newstead
Journal:  J Neurochem       Date:  1979-07       Impact factor: 5.372

4.  Activities of 3,4-dihydroxy-L-phenylalanine and 5-hydroxy-L-tryptophan decarboxylases in rat brain: assay characteristics and distribution.

Authors:  K L Sims; G A Davis; F E Bloom
Journal:  J Neurochem       Date:  1973-02       Impact factor: 5.372

5.  Enzymatic isotopic assay for and presence of beta-phenylethylamine in brain.

Authors:  J M Saavedra
Journal:  J Neurochem       Date:  1974-02       Impact factor: 5.372

6.  The inhibition of catecholamine biosynthesis by apomorphine.

Authors:  M Goldstein; L S Freedman; T Backstrom
Journal:  J Pharm Pharmacol       Date:  1970-09       Impact factor: 3.765

7.  Isolation of synaptosomal and synaptic plasma membrane fractions.

Authors:  C W Cotman
Journal:  Methods Enzymol       Date:  1974       Impact factor: 1.600

8.  Antagonistic effects of apomorphine and haloperidol on rat striatal synaptosomal tyrosine hydroxylase.

Authors:  J Christiansen; R F Squires
Journal:  J Pharm Pharmacol       Date:  1974-05       Impact factor: 3.765

9.  Dopaminergic neurons: an in vivo system for measuring drug interactions with presynaptic receptors.

Authors:  J R Walters; R H Roth
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1976-12       Impact factor: 3.000

10.  Do neuroleptics prevent the penetration of dopamine agonists into the brain?

Authors:  B H Westerink; A S Horn
Journal:  Eur J Pharmacol       Date:  1979-09-01       Impact factor: 4.432

View more
  9 in total

Review 1.  Aromatic L-amino acid decarboxylase: a neglected and misunderstood enzyme.

Authors:  M D Berry; A V Juorio; X M Li; A A Boulton
Journal:  Neurochem Res       Date:  1996-09       Impact factor: 3.996

2.  The effects of pargyline and 2-phenylethylamine on D1-like dopamine receptor binding.

Authors:  Mark D Berry
Journal:  J Neural Transm (Vienna)       Date:  2010-12-30       Impact factor: 3.575

3.  Overeating Behavior and Striatal Dopamine with 6-[F]-Fluoro-L-m-Tyrosine PET.

Authors:  Claire E Wilcox; Meredith N Braskie; Jennifer T Kluth; William J Jagust
Journal:  J Obes       Date:  2010-05-04

Review 4.  Trace amine-associated receptor 1-Family archetype or iconoclast?

Authors:  David K Grandy
Journal:  Pharmacol Ther       Date:  2007-07-17       Impact factor: 12.310

5.  Relationship of striatal dopamine synthesis capacity to age and cognition.

Authors:  Meredith N Braskie; Claire E Wilcox; Susan M Landau; James P O'Neil; Suzanne L Baker; Cindee M Madison; Jennifer T Kluth; William J Jagust
Journal:  J Neurosci       Date:  2008-12-24       Impact factor: 6.167

6.  Chronic L-dopa decreases serotonin neurons in a subregion of the dorsal raphe nucleus.

Authors:  Branden J Stansley; Bryan K Yamamoto
Journal:  J Pharmacol Exp Ther       Date:  2014-09-11       Impact factor: 4.030

7.  Pharmacological characterization of a high-affinity p-tyramine transporter in rat brain synaptosomes.

Authors:  Mark D Berry; Shannon Hart; Anthony R Pryor; Samantha Hunter; Danielle Gardiner
Journal:  Sci Rep       Date:  2016-11-30       Impact factor: 4.379

8.  Regulation of dopaminergic function: an [18F]-DOPA PET apomorphine challenge study in humans.

Authors:  S Jauhar; M Veronese; M Rogdaki; M Bloomfield; S Natesan; F Turkheimer; S Kapur; O D Howes
Journal:  Transl Psychiatry       Date:  2017-02-07       Impact factor: 6.222

Review 9.  L-Dopa and Brain Serotonin System Dysfunction.

Authors:  Branden J Stansley; Bryan K Yamamoto
Journal:  Toxics       Date:  2015-03-05
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.